Luxbright AB (publ) (STO:LXB)
Sweden
· Delayed Price · Currency is SEK 0.355
+0.002 (0.57%)
Mar 9, 2026, 3:54 PM CET
Luxbright AB Revenue
In the year 2025, Luxbright AB had annual revenue of 13.75M SEK with 14.25% growth. Luxbright AB had revenue of 7.21M in the half year ending December 31, 2025, with 743.22% growth.
Revenue
13.75M
Revenue Growth
+14.25%
P/S Ratio
3.34
Revenue / Employee
1.37M
Employees
10
Market Cap
45.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.75M | 1.71M | 14.25% |
| Dec 31, 2024 | 12.03M | 11.18M | 1,307.68% |
| Dec 31, 2023 | 854.70K | 43.00K | 5.30% |
| Dec 31, 2022 | 811.70K | 82.70K | 11.34% |
| Dec 31, 2021 | 729.00K | -636.00K | -46.59% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SpectraCure AB | 1.11M |
| ScandiDos AB | 61.26M |
| Qlife Holding AB | 324.00K |
| Neola Medical AB | 8.28M |
| SciBase Holding AB | 36.59M |
| Iconovo AB | 14.53M |
| Scandinavian Real Heart AB (Publ) | 153.10K |
| Arcoma AB | 130.80M |